Abstract
ARIs for diabetes: A series of 2-(3-benzyl-2-oxoquinoxalin-1(2H)-yl)acetic acid derivatives were designed and synthesized as inhibitors of aldose reductase (AR), a novel target for the treatment of diabetes complications. Most of the derivatives proved to be potent and selective, with IC50 values in the low nanomolar to micromolar range.
Original language | English |
---|---|
Pages (from-to) | 1913-1917 |
Number of pages | 5 |
Journal | ChemMedChem |
Volume | 8 |
Issue number | 12 |
DOIs | |
Publication status | Published - Dec 2013 |
Keywords
- aldehyde reductases
- aldose reductases
- diabetes complications
- inhibitors
- polyol pathway
- quinoxalines
- structure-activity relationships